Search results
Sight Sciences awarded $34m in Alcon patent infringement case
Medical Device Network via Yahoo Finance· 4 days agoSight Sciences has announced a positive trial verdict in a $34m patent infringement case against...
LG Energy Solution to tackle patent ‘free riders’
Just Auto via Yahoo Finance· 6 days agoLG Energy Solution has said a surge in patent infringement and market distortion caused by unlicensed use of its patented tech calls for “strong...
Supreme Court Changes the Patent Venue Landscape
The National Law Review· 2 days agoOn May 22, 2017, the Supreme Court of the United States issued its decision in TC Heartland LLC v. Kraft Food Group Brands LLC tightening restrictions on...
Apple Watch Ultra 3 — new reports says it’s coming this year
Tom's Guide via Yahoo News· 3 days agoMasimo sued Apple claiming that the Cupertino company infringed on a medical technology patent owned...
Patent Lawsuit Aims at Uncommon Defendant: the US Patent Office
Bloomberg Law· 6 days agoA patent infringement lawsuit filed in late March resembles thousands filed annually: it describes an invention, alleges it was used without permission, ...
China’s Supreme People’s Court Releases Summary of the Supreme People’s Court’s Annual Report on...
The National Law Review· 1 day agoOn April 24, 2024, China’s Supreme People’s Court (SPC) released the Summary of the Supreme People’s...
Why Apple Watch Ultra 1 is better to get right now than an Ultra 2
BGR· 4 days agoAt least, it was until Apple unveiled the new Apple Watch Ultra 2 during its iPhone 15 event last...
Sandoz reaches agreement with Amgen over patent dispute
KFGO· 5 days agoZURICH (Reuters) - Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. ...
Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab
AOL· 4 days agoGeneric and biosimilar manufacturer Sandoz AG (OTC:SDZNY) (OTC:SDZXF) reached an agreement on Tuesday with Amgen Inc (NASDAQ:AMGN) to resolve all patent litigation related to its U.S. denosumab ...
Paul T. Qualey
The National Law Review· 6 days agoPaul has experience in a variety of areas of intellectual property law with a particular emphasis on patent litigation in trial and appellate courts and at the International Trade Commission ...
